Messenger RNA vaccines for cancer immunotherapy: progress promotes promise

por Huff, Amanda L., Jaffee, Elizabeth M., Zaidi, Neeha
Publicado 2022

Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity

por Schuelke, Matthew R., Wongthida, Phonphimon, Thompson, Jill, Kottke, Timothy, Driscoll, Christopher B., Huff, Amanda L., Shim, Kevin G., Coffey, Matt, Pulido, Jose, Evgin, Laura, Vile, Richard G.
Publicado 2019

Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors

por Wongthida, Phonphimon, Schuelke, Matthew R, Driscoll, Christopher B, Kottke, Timothy, Thompson, Jill M, Tonne, Jason, Stone, Cathy, Huff, Amanda L, Wetmore, Cynthia, Davies, James A, Parker, Alan L, Evgin, Laura, Vile, Richard G
Publicado 2020

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

por Huff, Amanda L., Wongthida, Phonphimon, Kottke, Timothy, Thompson, Jill M., Driscoll, Christopher B., Schuelke, Matthew, Shim, Kevin G., Harris, Reuben S., Molan, Amy, Pulido, Jose S., Selby, Peter J., Harrington, Kevin J., Melcher, Alan, Evgin, Laura, Vile, Richard G.
Publicado 2018

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

por Driscoll, Christopher B., Schuelke, Matthew R., Kottke, Timothy, Thompson, Jill M., Wongthida, Phonphimon, Tonne, Jason M., Huff, Amanda L., Miller, Amber, Shim, Kevin G., Molan, Amy, Wetmore, Cynthia, Selby, Peter, Samson, Adel, Harrington, Kevin, Pandha, Hardev, Melcher, Alan, Pulido, Jose S., Harris, Reuben, Evgin, Laura, Vile, Richard G.
Publicado 2020

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

por Evgin, Laura, Huff, Amanda L., Wongthida, Phonphimon, Thompson, Jill, Kottke, Tim, Tonne, Jason, Schuelke, Matthew, Ayasoufi, Katayoun, Driscoll, Christopher B., Shim, Kevin G., Reynolds, Pierce, Monie, Dileep D., Johnson, Aaron J., Coffey, Matt, Young, Sarah L., Archer, Gary, Sampson, John, Pulido, Jose, Perez, Luis Sanchez, Vile, Richard
Publicado 2020

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

por Kottke, Timothy, Tonne, Jason, Evgin, Laura, Driscoll, Christopher B., van Vloten, Jacob, Jennings, Victoria A., Huff, Amanda L., Zell, Brady, Thompson, Jill M., Wongthida, Phonphimon, Pulido, Jose, Schuelke, Matthew R., Samson, Adel, Selby, Peter, Ilett, Elizabeth, McNiven, Mark, Roberts, Lewis R., Borad, Mitesh J., Pandha, Hardev, Harrington, Kevin, Melcher, Alan, Vile, Richard G.
Publicado 2021

Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection

por Delitto, Daniel, Zabransky, Daniel J., Chen, Fangluo, Thompson, Elizabeth D., Zimmerman, Jacquelyn W., Armstrong, Todd D., Leatherman, James M., Suri, Reecha, Lopez-Vidal, Tamara Y., Huff, Amanda L., Lyman, Melissa R., Guinn, Samantha R., Baretti, Marina, Kagohara, Luciane T., Ho, Won Jin, Azad, Nilofer S., Burns, William R., He, Jin, Wolfgang, Christopher L., Burkhart, Richard A., Zheng, Lei, Yarchoan, Mark, Zaidi, Neeha, Jaffee, Elizabeth M.
Publicado 2021

Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade

por Shu, Daniel H., Ho, Won Jin, Kagohara, Luciane T., Girgis, Alexander, Shin, Sarah M., Danilova, Ludmila, Lee, Jae W., Sidiropoulos, Dimitrios N., Mitchell, Sarah, Munjal, Kabeer, Howe, Kathryn, Bendinelli, Kayla J., Qi, Hanfei, Mo, Guanglan, Montagne, Janelle, Leatherman, James M., Lopez-Vidal, Tamara Y., Zhu, Qingfeng, Huff, Amanda L., Yuan, Xuan, Hernandez, Alexei, Coyne, Erin M., Zaidi, Neeha, Zabransky, Daniel J., Engle, Logan L., Ogurtsova, Aleksandra, Baretti, Marina, Laheru, Daniel, Durham, Jennifer N., Wang, Hao, Anders, Robert, Jaffee, Elizabeth M., Fertig, Elana J., Yarchoan, Mark
Publicado 2023